Cargando…
Fbxo7 promotes Cdk6 activity to inhibit PFKP and glycolysis in T cells
Fbxo7 is associated with cancer and Parkinson’s disease. Although Fbxo7 recruits substrates for SCF-type ubiquitin ligases, it also promotes Cdk6 activation in a ligase-independent fashion. We discovered PFKP, the gatekeeper of glycolysis, in a screen for Fbxo7 substrates. PFKP is an essential Cdk6...
Autores principales: | Harris, Rebecca, Yang, Ming, Schmidt, Christina, Royet, Chloe, Singh, Sarbjit, Natarajan, Amarnath, Morris, May, Frezza, Christian, Laman, Heike |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Rockefeller University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9178409/ https://www.ncbi.nlm.nih.gov/pubmed/35670764 http://dx.doi.org/10.1083/jcb.202203095 |
Ejemplares similares
-
Opposing effects on the cell cycle of T lymphocytes by Fbxo7 via Cdk6 and p27
por: Patel, Shachi P., et al.
Publicado: (2016) -
Analysis of the FBXO7 promoter reveals overlapping Pax5 and c-Myb binding sites functioning in B cells
por: Harris, Rebecca, et al.
Publicado: (2021) -
Beyond ubiquitination: the atypical functions of Fbxo7 and other F-box proteins
por: Nelson, David E., et al.
Publicado: (2013) -
Expression of Fbxo7 in Haematopoietic Progenitor Cells Cooperates with p53 Loss to Promote Lymphomagenesis
por: Lomonosov, Mikhail, et al.
Publicado: (2011) -
Defective erythropoiesis in a mouse model of reduced Fbxo7 expression due to decreased p27 expression
por: Randle, Suzanne J, et al.
Publicado: (2015)